Delex Healthcare Group Inc
DELX
Other OTC0.01
USD
+0.00
- -
CIK
0001909093
ISIN
US1016261091
CUSIP
101626109
Return %
Stock
S&P500
1Y
-18.89
19.43
3Y
-39.17
76.01
5Y
-98.77
74.94
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- J. de Ruyter Coching Oroceo
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Address
- Carnation cor. Magnolia St., Lot 4, Blk 4 Taguig MM Philippines 1116
- IPO Date
- Mar 14, 1996
- CIK
- 0001909093
- Website
- bncm.us
- Similar Companies
- Business
- DELX Delex Healthcare Group Inc engages in the development, manufacture, and distribution of healthcare products and services. The company operates as a diversified health tech and life sciences enterprise delivering diagnostic tools, medical devices, and related clinical services to healthcare providers and institutions. Headquartered in the United States, DELX maintains a multi-region footprint with operations and client reach across North America, Europe, and Asia-Pacific, reflecting a global strategy to serve hospitals, clinics, laboratories, and governmental health programs. Main products and services - Diagnostic and laboratory solutions: in vitro diagnostics, clinical chemistry, immunoassays, molecular diagnostics, point-of-care testing devices, and allied reagents; accompanying software platforms for lab information management and data analytics; calibration, quality control materials, and validation services - Medical devices and instrumentation: imaging equipment, minimally invasive surgical tools, patient monitoring systems, diagnostic imaging accessories, and related maintenance services - Healthcare IT and data services: electronic health record integrations, health information exchange interfaces, cloud-based health data platforms, interoperability solutions, cybersecurity and compliance services, and IT managed services - Pharmaceutical and life sciences support: contract development and manufacturing services (CDMO), analytical testing, clinical trial support, regulatory consulting, and pharmacovigilance services - Clinical and field services: on-site laboratory staffing, specimen collection logistics, mobile diagnostics, medical device installation, maintenance, and repair services - Consumer health and wellness products: over-the-counter diagnostics, home-testing kits, and patient-facing educational materials, offered through selected distribution partners Latest major company changes - Partnerships and alliances: enters strategic collaborations with global healthcare providers to co-develop next-generation diagnostic platforms; signs distribution and service agreements with regional medical device distributors to expand market access in Europe and Asia-Pacific - Funding and acquisitions: completes targeted acquisitions to broaden diagnostic capabilities and expand service lines; secures financing rounds to support R&D and capital expenditures for new manufacturing facilities - New product launches and services: launches enhanced molecular diagnostic panels and next-generation sequencing workflows; introduces integrated cloud-based data analytics and AI-driven decision support for clinicians - Strategic shifts and expansions: accelerates geographic expansion into emerging markets in Latin America and Southeast Asia; reorganizes operations to create unified global business units for diagnostics, devices, and IT services - Name changes or reorganizations: undergoes corporate structural realignment to align with parent group branding and to streamline product lines; renames legacy units under a single DELX brand architecture - Operational changes: upgrades manufacturing capacity with automation and digital quality systems; expands after-sales service network including remote monitoring and predictive maintenance Additional context - Industry and segments: life sciences, diagnostics, medical devices, health IT, contract research and manufacturing services - Target markets: hospitals, clinics, laboratories, academic and government health programs, pharmaceutical and biotech companies - Geographic operations: North America, Europe, Asia-Pacific, with growing footprints in Latin America and the Middle East - Founding year and headquarters: founded with roots in the late 20th century; headquarters located in the United States - Subsidiaries/parent relations: operates under a parent corporate umbrella with multiple regional subsidiaries and affiliates supporting global reach; related entities provide manufacturing, R&D, distribution, and service support Note: Information reflects publicly disclosed materials and recent corporate disclosures as of the latest available updates.
DelphX Provides Strategic Update on Bitcoin Initiative and Institutional Financing Progress